Goldman Sachs Maintains 10x Genomics Inc – (TXG) Sell Recommendation – 24/7 Wall St.
Fintel reports that on July 13, 2023, Goldman Sachs maintained coverage of 10x Genomics Inc – (TXG) with a Sell recommendation. Analyst Price Forecast Suggests 0.79% Downside As of July 6, 2023, the average one-year price target for 10x Genomics Inc – is 59.07. The forecasts range from a low of 25.25 to a high […]
Source: 247wallst.com